| Enhancer ID: | E_02_0613 |
| Species: | human |
| Position : | chr20:3079786-3081786 |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Neuromuscular diseases (certain neuromuscular disorders) |
| Pubmed ID: | 31461843 |
| Enhancer experiment: | PCR, Western blot, gene knockdown, gel electrophoresis |
| Enhancer experiment description: | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
| Target gene : | AVP |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
| TF name : | -- |
| TF experiment: | PCR,Western blot,????,???? |
| TF experiment description: | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
| Enhancer function : | Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
Arginine-vasopressin (AVP) promotes muscle differentiation, hypertrophy, and regeneration through the combined activation of the calcineurin and Calcium/Calmodulin-dependent Protein Kinase (CaMK) pathways. |
| SNP ID: | -- |
| GeneName | Pathway Name | Source | Gene Number |
|---|